Search

Breathing new life into patient care: Innovative partnership aims to transform interstitial lung disease support

Burlington, ON (October 25, 2023) – In a unique partnership, Boehringer Ingelheim (Canada) Ltd., St. Joseph's Healthcare Hamilton, and McMaster University have come together to transform the way patients are supported at the onset of a diagnosis

Alberta Boehringer Ingelheim collaboration fund announces new research for patients living with respiratory disease

ABIC-COPD

Discover the ABIC Fund, developed to advance health innovation projects in the area of respiratory diseases, like COPD, for Alberta-based investigators.

Boehringer Ingelheim Canada and community-based clinics join to revolutionize cardiovascular care in Ontario

New health projects empower Indigenous communities to address chronic diseases

COACH Program

The COACH Program addresses the unique needs of people living with heart failur and it's yielding promising results across Ontario. Find out more.

Boehringer Ingelheim Focuses COVID-19 Clinical Research on Alteplase

Equine asthma: Recognizing and managing respiratory issues in horses

Alberta Boehringer Ingelheim Collaboration aims to tackle care gaps in respiratory diseases

New data presented at the ISTH 2015 Congress show Idarucizumab* results in immediate reversal of dabigatran in patients requiring urgent medical procedures or with serious bleeding complications1,2

About Us

Human Health

Animal Health

Science & Innovation

Partnering

Careers